Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Paintaud

Showing results (41-50 of 151) with videos related to

Pageof 16
Sort By:
Therapie|August 5, 2006
[Chemical submission: a literature review]Pauline Saint-Martin, Yves Furet, Patrick O'Byrne, et al.
Pharmacogenetics and Genomics|December 11, 2013
Influence of FcγRIIIA genetic polymorphism on T-lymphocyte depletion induced by rabbit antithymocyte globulins in kidney transplant patientsDavid Ternant, Matthias Büchler, Gilles Thibault, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|December 11, 2013
Lung and serum teicoplanin concentration after aerosol and intravenous administration in a rat modelEmmanuelle Mercier, François Darrouzain, Jerome Montharu, et al.
Clinical Colorectal Cancer|November 21, 2017
Monoclonal Antibodies Targeting the IL-17/IL-17RA Axis: An Opportunity to Improve the Efficiency of Anti-VEGF Therapy in Fighting Metastatic Colorectal Cancer?Sajida Ibrahim, Alban Girault, Marc Ohresser, et al.
Arthritis Research & Therapy|June 7, 2011
Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative studyDenis Mulleman, Francine Lauféron, Daniel Wendling, et al.
Therapeutic Drug Monitoring|July 22, 2008
Infliximab pharmacokinetics in inflammatory bowel disease patientsDavid Ternant, Alexandre Aubourg, Charlotte Magdelaine-Beuzelin, et al.
Therapeutic Drug Monitoring|June 2, 2017
Immunoassays for Measuring Serum Concentrations of Monoclonal Antibodies and Anti-biopharmaceutical Antibodies in PatientsFrançois Darrouzain, Sumin Bian, Céline Desvignes, et al.
British Journal of Clinical Pharmacology|December 21, 2004
Bayesian estimation of cyclosporin exposure for routine therapeutic drug monitoring in kidney transplant patientsHélène Bourgoin, Gilles Paintaud, Matthias Büchler, et al.
Bioanalysis|June 6, 2015
Development and validation of an enzyme-linked immunosorbent assay to measure adalimumab concentrationCéline Desvignes, Soujanya R Edupuganti, François Darrouzain, et al.
Cancer Research|July 3, 2004
Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationshipSébastien Dall'Ozzo, Sophie Tartas, Gilles Paintaud, et al.
Pageof 16

Showing results (41-50 of 151) with videos related to

Sort By:
Pageof 16
Therapie|August 5, 2006
[Chemical submission: a literature review]Pauline Saint-Martin, Yves Furet, Patrick O'Byrne, et al.
Pharmacogenetics and Genomics|December 11, 2013
Influence of FcγRIIIA genetic polymorphism on T-lymphocyte depletion induced by rabbit antithymocyte globulins in kidney transplant patientsDavid Ternant, Matthias Büchler, Gilles Thibault, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|December 11, 2013
Lung and serum teicoplanin concentration after aerosol and intravenous administration in a rat modelEmmanuelle Mercier, François Darrouzain, Jerome Montharu, et al.
Clinical Colorectal Cancer|November 21, 2017
Monoclonal Antibodies Targeting the IL-17/IL-17RA Axis: An Opportunity to Improve the Efficiency of Anti-VEGF Therapy in Fighting Metastatic Colorectal Cancer?Sajida Ibrahim, Alban Girault, Marc Ohresser, et al.
Arthritis Research & Therapy|June 7, 2011
Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative studyDenis Mulleman, Francine Lauféron, Daniel Wendling, et al.
Therapeutic Drug Monitoring|July 22, 2008
Infliximab pharmacokinetics in inflammatory bowel disease patientsDavid Ternant, Alexandre Aubourg, Charlotte Magdelaine-Beuzelin, et al.
Therapeutic Drug Monitoring|June 2, 2017
Immunoassays for Measuring Serum Concentrations of Monoclonal Antibodies and Anti-biopharmaceutical Antibodies in PatientsFrançois Darrouzain, Sumin Bian, Céline Desvignes, et al.
British Journal of Clinical Pharmacology|December 21, 2004
Bayesian estimation of cyclosporin exposure for routine therapeutic drug monitoring in kidney transplant patientsHélène Bourgoin, Gilles Paintaud, Matthias Büchler, et al.
Bioanalysis|June 6, 2015
Development and validation of an enzyme-linked immunosorbent assay to measure adalimumab concentrationCéline Desvignes, Soujanya R Edupuganti, François Darrouzain, et al.
Cancer Research|July 3, 2004
Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationshipSébastien Dall'Ozzo, Sophie Tartas, Gilles Paintaud, et al.
Pageof 16